| Title |
Insights into respiratory microbiome composition and systemic inflammatory biomarkers of bronchiectasis patients / |
| Authors |
Konovalovas, Aleksandras ; Armalytė, Julija ; Klimkaitė, Laurita ; Liveikis, Tomas ; Jonaitytė, Brigita ; Danila, Edvardas ; Bironaitė, Daiva ; Mieliauskaitė, Diana ; Bagdonas, Edvardas ; Aldonytė, Rūta |
| DOI |
10.1128/spectrum.04144-23 |
| Full Text |
|
| Is Part of |
Microbiology spectrum.. American Society for Microbiology. 2024, vol. 12, no. 12, p. [1-18].. eISSN 2165-0497 |
| Abstract [eng] |
The population of microorganisms on/in the human body resides in distinct local microbiomes, including the respiratory microbiome. It remains unclear what defines a healthy and a diseased respiratory microbiome. We investigated the respiratory microbiome in chronic pulmonary infectious disease, i.e., bronchiectasis, and researched correlations between microbiome composition, systemic inflammatory biomarkers, and disease characteristics. The bronchoalveolar microbiome of 47 patients was sequenced, and their serum inflammatory mediators were quantified. The microbiomes were grouped based on their content and diversity. In addition, patients were also grouped into low- and high-response groups according to their inflammatory biomarkers’ levels. Certain microbiome compositions, mainly single-species dominated, were associated with high levels of inflammatory cytokines, whereas others correlated with low inflammatory response and remained diverse. We conclude that respiratory microbiome composition is a valuable resource for the diagnostics and personalized management of bronchiectasis, which may include preserving microbiome diversity and introducing possible probiotics. |
| Published |
American Society for Microbiology |
| Type |
Journal article |
| Language |
English |
| Publication date |
2024 |
| CC license |
|
